New bone drug goes Head-to-Head with market leader
NCT ID NCT05345691
Summary
This study tested whether a new osteoporosis drug called Bmab 1000 works as well as the established medication Prolia. Researchers enrolled 479 postmenopausal women with osteoporosis and randomly assigned them to receive either the new drug or Prolia via injection every six months. The main goal was to see if both treatments improved bone mineral density to a similar degree over one year.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
PPD Global Ltd, Granta Park, Great Abington,
Cambridge, UK, CB21 6GQ, United Kingdom
Conditions
Explore the condition pages connected to this study.